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 1 
Introduction 
 
Glycosaminoglycans (GAGs) are long linear polysaccharides constructed by 
repeating disaccharide units. The repeating unit consists of an hexosamine 
[N-acetylglucosamine (GlcNAc) or N-acetylgalactosamine (GalNAc)] along with 
a uronic acid [glucuronic acid (GlcA) or iduronic acid (IdoA)] or galactose.
1,2)
 GAGs 
ubiquitously exist in the extracellular matrix and cartilaginous tissues with molecular 
weight raging from thousands to hundreds of thousands, and are always attached to 
the serine residue of the core protein to form proteoglycan (PG), playing an important 
physiological role through the interaction with growth factor or cell adhesion 
molecules.
3,4)
  
Chondroitin sulfate (CS), heparin (HP), heparan sulfate (HS) and hyaluronic acid 
(HA) have been well known as the representative GAG (Fig. I). Especially, CS 
consists of the disaccharide repeating units of the structure [→4)-β-D-GlcA- 
(1→3)-β-D-GalNAc (β1→] n, which can be substituted with O-sulfo groups at various 
positions. CS has been well studied for its anti-inflammatory function and 
chondroprotective properties
5-10)
 and as the major component of articular cartilage, 
nowadays CS has been developed as the commercial drug or dietary supplement for 
the treatment or improvement of arthritic diseases such as osteoarthritis (OA). 
However, because CS always bears highly negative surface charge and possesses high 
molecular weight (5 ~ 50 kDa),
11-14)
 it is difficult for CS to be effectively absorbed 
through the gastrointestinal tract. On the other hand, heparin consists of a variably 
sulfated repeating disaccharide unit that comprises glucuronic acid or iduronic acid 
along with glucosamine. Heparin is a heterogeneous poly-dispersed mixture of 
polysaccharides raging from 3 ~ 30 kDa in molecular weight with an average 
molecular mass of 15 kDa.
15-17)
 Heparin is widely used as an anticoagulant in the 
clinical researches and has antithrombotic efficacy.
18-20)
 Whereas, similarly to CS, the 
oral absorption efficiency of heparin is undesirable as well owing to its large 
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molecular size and highly negative surface charge density. Therefore, heparin can 
only be injected intravenously or subcutaneously, which limits its application. 
(a) 
Chondroitin Sulfate (Mw. 5 ~ 50 kDa)  
GlcA
O O
O O
OH
OH
COOH
NHCOCH3
O O
O O
OH
OH
COOH
NHCOCH3
n
R2O
OR1
R2O
OR1
R1=H or SO3
-,  R2=SO3
- or H
GalNAc GlcA GalNAc
 
(b) 
Heparin (Mw. 3 〜 30 kDa)
O O
O
O
OR2
OH
COOH
NHR1
OR2
O O
O
O
OR2
OH
COOH
NHR1
OR2
n
R1=Ac or SO3
-, R2=H or SO3
-
OR2 OR2
GlcA GlcNAc GlcA GlcNAc
O O
O
O
OR2
OH
COOH
NHR1
OR2
O O
O
O
OR2
OH
COOH
NHR1
OR2
n
R1=Ac or SO3
-, R2=H or SO3
-
OR2 OR2
IdoA GlcNAc IdoA GlcNAc
 
    Fig. I Structures of glycosaminoglycans. 
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Polyamines (putrescine: PUT, spermidine: SPD and spermine: SPM) (Fig. II), 
ubiquitously distributed in natural products at high concentrations, are organic 
molecules having two or more primary amino, –NH2 groups.
21,22)
 Intracellular 
polyamines exist as polyamine-RNA complexes, despite their binding affinity for 
other acidic molecules, such as DNA, phospholipids and ATP. Selective structural 
changes of specific RNA structures by polyamines have been suggested to play an 
important role in cellular proliferation and differentiation.
21,23)
 
 
Putrescine (PUT) Spermidine (SPD)
Spermine (SPM)  
Fig. II Structures of polyamines. 
 
Polyamines bound to nucleic acids can induce aggregation, structural changes of 
DNA and can stabilize DNA in vitro.
24-28)
 Based on these insights, SPM and 
polyamine analogs such as poly (L-lysine), polyethylenimine, etc., have been 
examined for the construction of nanoparticles containing siRNA or plasmid DNA for 
delivering genes to specific target organs or cultured cells.
29-34)
 Interestingly, poly-ion 
complex (PIC) formation through the electrostatic interaction between polylysine and 
CS, has been reported.
35)
 This report inspired us to attempt to prepare PICs by mixing 
glycosaminoglycans and natural polyamines in aqueous solutions and investigate their 
effect on GAG oral absorption. Since polyamines are found at high concentrations in 
natural foods, they are considered to have extremely low toxicity. 
In the present study, the efficient formation of PICs from GAGs and polyamines 
has been accomplished. The dependence on the mixing ratio between GAGs and 
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polyamines, molecular weight of GAGs, nature of polyamines, and the pH for PIC 
formation have been investigated. The preparation of PICs, simultaneously possessing 
high formation efficiency and nearly neutral surface charges, that were considered to 
be important factors for the oral absorption of CS, was established from 15 kDa of CS 
and SPM. These results suggest that PIC generated by the interaction of CS and 
polyamines might represent a promising core structure for the development of CS 
delivery system in gastrointestinal tract. In addition, studies are underway for 
investigating the efficacy of PIC generated from heparin. 
 5 
Chapter 1   
The formation and characterization of poly-ion complex generated 
through the interaction between chondroitin sulfate and polyamines 
 
1.1. Introduction 
    Chondroitin sulfate (CS), a sulfated linear glycosaminoglycan (GAG), is 
constructed by disaccharide repeating units of the structure [→4)-β-D-GlcA- 
(1→3)-β-D-GalNAc (β1→]n, where GlcA represents glucuronic acid and GalNAc 
means N-acetylgalactosamine,
36)
 which can be substituted with O-sulfo groups at 
various positions (Fig. 1-1). CS contains, on average, one sulfo group per 
disaccharide repeating unit at either C-4 or C-6 position of GalNAc. The “A-type 
unit,” defined as [→4)-β-D-GlcA- (1→3)-β-D-GalNAc4S (β1→] (where “S” 
designates a sulfo group) is a predominant disaccharide in mammalian or chicken 
tracheal cartilage CS, while the “C-type unit,” defined as [→4)-β-D-GlcA- 
(1→3)-β-D-GalNAc6S (β1→], is a major disaccharide found in shark or salmon 
nasal cartilage CS.
37,38)
 CS is widely distributed in animal tissues and may play an 
important role in different types of metabolic reactions as well as a protective agent 
of the joints, the internal walls of blood vessels, skin, bones, etc.  
 
 
 
 
 
 
 
 
Fig. 1-1 Structures of unsaturated chondro-disaccharides. 
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Since CS stabilizes fibrous and cellular elements of the connective tissue and at 
the same time lubricates and protects the membranes in joints,
39-42)
 CS has become 
increasingly popular as an ingredient in health foods for the symptomatic treatment 
of joint diseases, such as joint rheumatism and osteoarthritis. However, CS is poorly 
absorbed through the gastrointestinal tract on account of its high molecular weight (5 
~ 50 kDa) and highly negative surface charge.
11-14)
 Therefore, development of CS 
absorption system through the intestinal barrier is one of the critical challenges for 
the successful application of CS in the treatment of osteoarthritis. 
There have been several reports demonstrating that the preparation of 
self-assembling micelles as the CS drug carrier system was developed based on the 
conjugation with α-linoleic acid.43) In addition, novel nanomaterials are being 
developed to improve the oral bioavailability of low molecular mass compounds, 
proteins, and recombinant DNAs.
44)
 Thus, there is the possibility that some 
nanomaterial or macromaterial may be useful for the development of less expensive 
and safer delivery systems for oral intake of CS. 
    Under the inspiration of poly-ion complex (PIC), we attempt to mix CS and 
natural polyamines in aqueous solutions and investigate how the product effects on 
CS oral absorption. In the current study, we have successfully generated PIC with 
high formation efficiency utilizing CS and polyamines. Furthermore, the dependence 
on the mixing ratio between CS and polyamines, molecular weight of CS, nature of 
polyamines, and the pH for PIC formation have been investigated. The combination 
of 15 kDa CS and SPM has accomplished the preparation of PIC simultaneously 
possessing high formation efficiency and nearly neutral surface charges, and has been 
demonstrated to significantly facilitate the oral absorption efficiency of CS. These 
results indicate that PIC generated by the interaction between CS and polyamines 
might represent a promising core structure for the improvement of CS bioavailability 
in the digestive system. 
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1.2. Experimental 
1.2.1. Chemicals and Materials 
Chondroitin sulfate-A (average molecular weight: 15 kDa, 14.0% of ΔDi-0S, 
49.8% of ΔDi-4S, 36.1% of ΔDi-6S) from bovine tracheal cartilage was purchased 
from Shin-Nippon Yakugyo Co., Ltd. (Tokyo, Japan). Chondroitin sulfate-C (Mw. avg 
46 kDa, 1.77% of ΔDi-0S, 13.7% of ΔDi-4S, 70.8% of ΔDi-6S, 2.89% of ∆Di-diSE, 
10.8% of ∆Di-diSD) from shark cartilage, chondroitinase ABC (Proteus vulgaris EC 
4.2.2.4), the unsaturated disaccharides (∆Di-0S, ∆Di-4S, ∆Di-6S, ∆Di-diSE, 
∆Di-diSB, ∆Di-diSD, and ∆Di-triS) were purchased from Seikagaku Corp. (Tokyo, 
Japan). Fractioned CS standard samples (Mw. 6 kDa, 13 kDa, 31 kDa; 44 kDa) for 
molecular weight determination were prepared as described previously in literature.
45)
 
Spermine tetrahydrochloride (SPM·4HCl) was obtained from Nacalai Tesque Inc. 
(Kyoto, Japan). Tetrabutylammonium hydrogen sulfate (TBA) and titanium dioxide 
(anatase type, average particle size, 50 μm) were obtained from Wako Pure Chemical 
Co. (Osaka, Japan). 2-cyanoacetamide and deuterium oxide (D2O, 99.96 atom% D) 
were obtained from Sigma-Aldrich Co. LLC. (St Louis, MO, USA). Water used in 
studies was purified using Q-GARD
®
 1, Millipore. All other chemicals were of 
analytical reagent grade and used without further purification. 
 
1.2.2. PIC Formation 
CS and polyamines were separately dissolved in double-distilled water, with a 
doubled concentration of the target PIC, and then equivalent volumes of CS solution 
and polyamine solution were fully mixed with one another to generate PIC. PIC 
formation efficiency was evaluated by turbidimetric measurement, namely the 
determination of % transmittance (T), using thermo scientific SPECTONIC 20D+ 
digital spectrophotometer. 
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1.2.3. The Effect of pH Value on the PIC Formation Efficiency 
A 100 μL aliquot of 50 mM SPM aqueous solution was fully mixed with the 
equal volume of 40 mg/mL of CS, and then the solutions containing PIC were 
separately adjusted to pH value 1~9 using 1 M HCl or 1 M NaOH. PIC fraction, 
obtained by the centrifugation at 6,000 g for 5 min, was suspended and precipitated 
twice, using 1 mL of pH conditioned H2O to remove the free SPM and CS that did not 
form PIC. Since PIC formation was unstable under basic conditions (pH value above 
9), 400 μL aliquot of 0.2 M NaOH was added to the PIC pellets to dissociate CS and 
SPM from each other. Free SPM was separated from CS using Amicon
® 
Ultra 10 K 
spin columns by centrifugation at 6,000 g for 30 min at 4°C, and then the separated 
CS and SPM samples were quantitatively analyzed by high-performance liquid 
chromatography (HPLC) (Fig. 1-2). 
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50 mM SPM 100 µL
add 40 mg/mL CS-A     100 µL 
vortex
adjust pH 1 ~ 9 with 1 M HCl and 1 M NaOH
add H2O (pH 1 ~ 9) (adjusted with 1 M HCl and 1 M NaOH)    800 µL 
centrifuge at 6,000 g for 5 min
PIC pellet
wash with H2O (pH 1 ~ 9)    1 mL
centrifuge at 6,000 g for 5 min
Pure PIC pellet
add 0.2 M NaOH 400 µL
result in pH ＞ 11, basic condition, PIC dissociation
centrifuge with 10 K spin column at 6,000 g for 30 min
Lower solution (SPM)
add 100% TCA (adjust to 5% TCA) 21.05 µl
Submit to HPLC 20 µL
Membrane (CS-A)
wash with H2O 500 µL
centrifuge at 6,000 g for 30 min at 4℃
Pure CS-A
add H2O 500 µL
suspend and transfer to new eppendorf tube
Lyophilize
add H2O 200 µL
Submit to HPLC 20 µL
2 times
2 times
 
Fig. 1-2 Isolation of CS and SPM from PIC. 
 
HPLC Conditions 
The HPLC system for CS quantitative analysis comprised two DP-8020 Pumps 
(Tosoh Corporation, Tokyo, Japan) as the gradient eluent pumps and an NP-FX (II) -1 
MINICHEMI Pump (Nihon Seimitsu Kagaku Co. Ltd, Tokyo, Japan) as the 
post-column reaction solution pump. An AS-8020 (Tosoh Corporation, Tokyo, Japan) 
Auto Sampler, a CO631A (GL Sciences Inc., Tokyo, Japan) Column Oven, a DB-5 
(Shimamura Instrument Co., Tokyo, Japan) Dry Reaction Bath, an FP-1520S (Jasco 
Corporation, Tokyo, Japan) Intelligent Fluorescence Detector and a DGU-12A 
(Shimadzu Corporation, Kyoto, Japan) Degasser were also applied to this HPLC 
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analysis system. Here, an Asahipak NH2P-50 4E column (4.6 mm i.d. × 250 mm, 5 
μm, Showa Denko K.K., Tokyo, Japan) was used along with a guard column Asahipak 
NH2P-50G 4A (4.6 mm i.d. × 10 mm, 5 μm, Showa Denko K.K., Tokyo, Japan). The 
mobile phases: (A) 0.1 M sodium carbonate buffer (pH 10.0) containing 0.1 M NaCl 
and (B) 0.1 M sodium carbonate buffer (pH 10.0) containing 1.0 M NaCl were eluted 
according to the following gradient program: 0 - 20 min (0 - 100% B), 20 - 25 min 
(100% B), 25 - 27 min (100 - 0% B), 27 - 35 min (0% B) (for initialization). And the 
flow rate was constantly maintained at 0.5 mL/min. The post-column reaction 
reagents (1) and (2) were 50 mM guanidine and 1.0 M NaOH, respectively, and the 
flow rates were both maintained at 0.25 mL/min. The column was kept at the room 
temperature and the post-column reaction temperature was set at 120°C. The reaction 
mixture passed the reaction coil (0.5 mm i.d. × 10 m), fully heated in the reactor to 
accelerate the reaction, and then was cooled down in the cooling coil (0.25 mm i.d. × 
5 m). The detection wavelength was set at 425 nm with 320 nm of excitation. 0.05, 
0.1, 0.5, 1, 2 and 4 μg of CS (Mw. 15 kDa) were used as the standard samples to plot 
the calibration curve for quantitatively determining CS contents in PIC. 
The HPLC system for polyamine quantitative analysis comprised an ELITE 
LaChrom L-7110 Pump (Hitachi High-Technologies Corporation, Tokyo, Japan) as 
the eluent pump, an NP-FX (II) -1 MINICHEMI Pump (Nihon Seimitsu Kagaku Co. 
Ltd, Tokyo, Japan) as the post-column reaction solution pump, an ELITE LaChrom 
L-7200 (Hitachi High-Technologies Corporation, Tokyo, Japan) Auto Sampler, an 
ELITE LaChrom L-7300 (Hitachi High-Technologies Corporation, Tokyo, Japan) 
Column Oven and an FP-1520S (Jasco Corporation, Tokyo, Japan) Intelligent 
Fluorescence Detector. A TSK gel Polyaminepak column (4.6 mm i.d. × 50 mm, 
Tosoh Corporation, Tokyo, Japan) was applied in this study and the mobile phase 
(containing 0.35 M Sodium-citrate, 2 M NaCl, 20% methanol, 0.1% Brij-35 and 
0.01% N-capric acid (pH 5.3)) was constantly maintained at 0.42 ml/min. The flow 
rate of the post-column reaction reagent (containing 0.4 mM Borate-KOH, 0.06% 
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o-phthalaldehyde, 37 mM β-mercaptoethanol and 0.1% Briji-35) was also set at 0.42 
ml/min. The column temperature was set at 50°C and the detection wavelength was 
set at 470 nm with 336 nm of excitation. 5 μM of SPM dissolved in 5% TCA was 
utilized as the standard sample. 
 
1.2.4. Preparation of Low Molecular Weight Chondroitin Sulfate 
Low molecular weight (LMW) CS was prepared by photochemical 
depolymerization with titanium dioxide (TiO2) as described in previous literatures 
with minor modifications.
46,47)
 The photochemical reaction device (Sen Lights 
Corporation, Osaka, Japan) consisted of a VG1500 reaction tank with 5 inlets, a light 
source (high pressure mercury lamp HL100 CH-4, 100W), a power source 
(HB100P-1) and water-cooling jacket JW-1G. The apparatus was connected with a 
water circulating system to cool the lamp. 
Briefly, 1 g of CS-A (Mw. 15 kDa) was dissolved in 100 mL of H2O with 100 mg 
of TiO2 in the VG1500 reaction tank. After being exposed to the light for specified 
time, molecular weight of CS was monitored by gel permeation chromatography 
(GPC)-HPLC to obtain 8 kDa and 5 kDa of LMWCS.
45) 
After the reaction, the sample 
was centrifuged at 1,500 g for 5 min at 20°C and the supernatant was filtered through 
0.45 µm disposable syringe filter unit (Dismic-13HP; Advantec, Tokyo, Japan) to 
eliminate all of the TiO2 particles. Then the product solution was neutralized with 
NaOH, followed by dialysis against water using Spectra/Por® Dialysis Membrane 
MWCO: 3,500 and ultimately the obtained solution was lyophilized to prepare the 
LMWCS powder sample. 
 
HPLC Conditions 
The GPC-HPLC system for molecular weight determination consisted of an 
L-6000 Pump (Hitachi High-Technologies Corporation, Tokyo, Japan) equipped with 
a Rheodyne Model-7725 Injector with 20 μL Sample Loop (Rheodyne Inc., Cotati, 
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CA, USA), an SPD-6A UV Spectrophotometric Detector (Shimadzu Corporation, 
Kyoto, Japan) set at 204 nm, and a D-2500 Chromato Integrator (Hitachi 
High-Technologies Corporation, Tokyo, Japan). The molecular weight of CS was 
determined using gel permeation chromatography with Asahipak GF-510 HQ column 
(7.5 mm i.d. × 300 mm, 5 μm, Showa Denko K.K., Tokyo, Japan). Isocratic elution 
with 10 mM NH4HCO3 was used at a flow rate of 0.3 mL/min. The fractioned CS 
standard samples (average molecular weight 6, 13, 31 and 44 kDa) were applied to 
construct the calibration curve using the retention time plotted against the 
antilogarithm of molecular weight. Thereby, the average molecular weight of the 
photodegraded CS was calculated from this calibration curve. 
 
Structural Analysis of LMWCS by 
1
H-NMR Spectroscopy 
The chemical structures of CS (Mw. 15 kDa) and LMWCS (Mw. 5 kDa) were 
verified using proton nuclear magnetic resonance (
1
H-NMR) spectroscopy on 
JNM-ECS400 (Jeol Resonance Inc., Tokyo, Japan). 4 mg of each sample was 
repeatedly dissolved in 600 μl of D2O and lyophilized for twice. The obtained residue 
was redissolved in 600 μl of D2O and transferred into a 528-pp-8 NMR sample tube 
(5.0 mm O.D. × 25 cm, Wilmad-Lab Glass, Vineland, New Jersey, USA) for 
determination. 
 
1.2.5. Particle Size and ζ-Potential Determination 
    The mean particle sizes of various kinds of PIC samples were determined by 
dynamic light scattering (DLS) method on the MICROTRAC 9340 UPA-UT151 
(Nikkiso Co., Ltd, Tokyo, Japan) equipped with a semi-conductor laser at the 
wavelength of 780 nm. The ζ-potential determinations were performed for each PIC 
samples on the ELS-Z1 (Otsuka Electronics Co., Ltd, Osaka, Japan) at the 60 V of 
voltage. Double-distilled water was used as the dispersant and the measurements were 
carried out at 25°C. The average of three measurements was taken as the final 
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characteristic parameter. 
 
1.2.6. Surface Structure Analysis 
    PIC samples generated from CS and polyamines were characterized by Olympus 
BX51 upright microscope with Olympus DP-70 color camera (Olympus Optical Co., 
Ltd, Tokyo, Japan) for the particle morphology. 10 μL of aqueous PIC sample was 
poured on a microscope slide to form a sample film for observation. 
 
1.2.7. Absorption of Orally Administered PIC in Mice 
    All animal experiments were approved by the Institutional Animal Care and Use 
Committee of Chiba University and carried out according to the guidelines for Animal 
Research of Chiba University. The ddY mice (female, weighing 28 - 30 g, Japan SLC, 
Inc, Shizuoka, Japan) were housed at 25°C and 55% RH. A 12 h dark/light cycle was 
maintained throughout. Mice had free access to standard pellet diet (MF, Oriental 
Yeast Co., Ltd, Tokyo, Japan) and tap water, and were fasted overnight before the 
experiment. The solution containing PIC or CS alone was orally administered to each 
group (containing 6 - 9 mice) at a single dose of 500 mg CS/kg body weight (ca. 15 
mg/each animal). Blood samples were collected from the tail vein at time intervals of 
0, 0.5, 1, 2, 4, 6, 8, 10 h after oral administration and were anticoagulated with 3.2% 
trisodium citrate solution at the ratio of blood : 3.2% trisodium citrate = 9 : 1. Each 
collected sample was immediately centrifuged at 800 g for 15 min to obtain the 
plasma, which was transferred to a new Eppendorf tube and stored in a deep freezer 
until used (Fig. 1-3). Additionally, inflammation and wound damage at the digestive 
system of animals were checked by surgical operation after oral dose of samples. 
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CS alone  or  PIC
Orally administered by gavage
of 500 mg CS/kg body weight
ddY ♀
8-weeks old
Be fasted overnight
before the experiment
Take blood from the tail vein
at 0 h, 0.5 h, 1 h, 2 h, 4 h, 6 h, 8h, 10h
Blood : 3.2% trisodium citrate 
solution = 9 : 1 (anticoagulant)
4 ℃,  800 g
15 min  centrifugation
Plasma (stored in deep freezer)  
Fig. 1-3 Schedule of oral administration of PIC in animal models. 
 
 
1.2.8. Determination of CS Contents in Mouse Plasma 
    As shown in Fig. 1-4, mouse plasma (25 μL) was treated with 1.3 μL of 100% 
trichloroacetic acid (TCA) (final 5% TCA) and incubated at 4°C for 30 min to obtain 
free CS. After centrifugation at 20,000 g for 10 min, 15 μL of supernatant was 
neutralized with 1.5 μL of 2 M NaOH and diluted with 200 μL of H2O. The buffer of 
sample solution was firstly exchanged with 0.2 M tris-acetate (pH 8.0) using Amicon
®
 
Ultra 3 K spin columns (EMD Millipore Co., MA, USA), followed by buffer 
exchange with H2O. After the collected pure samples were lyophilized, the residues 
obtained were dissolved in 12.5 μl of H2O, and then 2.5 μl of 0.2 M tris-acetate buffer 
(pH 8.0) and 2.5 μl of 0.1 U/10 μl chondroitinase ABC were serially added to each 
sample. After incubation at 37°C for 18 h, the samples were heated at 100°C for 3 min 
to inactivate the enzymes and lyophilized again. Finally, the obtained powder samples 
were redissolved in 60 μl of H2O and 20 μl of each sample was submitted to the 
unsaturated disaccharide composition analysis HPLC system.  
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Plasma 25 µL
add 100% Trichloroacetic acid (TCA) (adjust to 5% TCA) 1.3 µL
vortex
stand at 4℃ for 30 min
centrifuge at 20,000 g for 10 min at 4℃
Supernatant 15 µL
add 2M NaOH 1.5 µL
add H2O  200 µL
Sample on ultra filtration membrane (Amikon Ultra 3K)
centrifuge at 12,500 g for 15 min
wash with 0.2 M tris-acetate buffer (pH 8.0) 200 µL
centrifuge at 12,500 g for 15 min
turn device upside down in clean tube (vortex)
centrifuge at 1,000 g for 10 min
add H2O 200 µL
centrifuge at 1,000 g for 10 min
Lower solution
lyophilize
add H2O  12.5 µL
add 0.2 M Tris-acetate buffer (pH 8.0) 2.5 µL
add 0.1 U/10 µL chondroitinase ABC 2.5 µL
incubate at 37℃ for 18 h
heat at 100℃ for 3 min
lyophilize
add H2O 60 µL
Submit to HPLC 20 µL
3 times
2 times
 
Fig. 1-4 Pretreatment of plasma for free CS extraction and procedures for CS 
disaccharide composition analysis by HPLC. 
 
 
HPLC Conditions 
The post-column HPLC system for unsaturated disaccharide composition 
analysis applied the same instruments as CS quantitative analysis. In this study, a 
DOCOSIL SP100 column (4.6 mm i.d. × 150 mm, 5 μm, Senshu Scientific Co., Ltd, 
Tokyo, Japan) was used along with a guard column DOCOSIL SP100 (4.6 mm i.d. × 
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30 mm, 5 μm, Senshu Scientific Co., Ltd, Tokyo, Japan). The mobile phases (A) 12% 
MeOH containing 1.2 mM TBA and (B) 12% MeOH containing 0.2 M NaCl and 1.2 
mM TBA were eluted according to the following gradient program: 0 - 10 min (1% B), 
10 - 11 min (1 - 10% B), 11 - 30 min (10% B), 30 - 35 min (10 - 60% B), 35 - 40 min 
(60% B), 40 - 41 min (60 - 1% B), 41 - 50 min (1% B) (for initialization). And the 
flow rate was constantly maintained at 1.0 ml/min. The post-column reaction reagents 
(1) and (2) were 0.5% 2-cyanoacetamide and 1.0 M NaOH, respectively. And the flow 
rates were both maintained at 0.25 ml/min. The column temperature was set at 60°C 
and the post-column reaction temperature was set at 110°C. The detection wavelength 
was set at 410 nm with 346 nm of excitation. The mixture containing 4 μg/mL of each 
unsaturated chondro-disaccharide was utilized as the standard sample. 
 
1.2.9. Preparation of Unusual Polyamines 
    Tris (3-aminopropyl) amine was purchased from Tokyo Chemical Industry Co. 
(Tokyo, Japan). Tetrakis (3-aminopropyl) ammonium, caldopentamine and 
caldohexamine were chemically synthesized as reported previously in the literature.
48)
 
The chemical structures of unusual polyamines were illustrated in Fig. 1-5 and all 
polyamines used in the study were in the form of their hydrochloride salts. When the 
unusual polyamine solutions were mixed with 15 kDa of CS to form PICs, the 
procedures were similar to those described above. 
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Tetrakis (3-aminopropyl) ammonium (Taa)Tris (3-aminopropyl) amine (Mitsubishine)
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Fig. 1-5 The chemical structures of unusual polyamines. 
 
 
 
 
 
1.3. Results and Discussion 
1.3.1. Preparation of Poly-ion Complex 
    At first, we examined whether polyamine spermine (SPM) could aggregate with 
commercially available CS-A (Mw. 15 kDa) prepared from bovine tracheal cartilage. 
As shown in Fig. 1-6, the aqueous solution containing CS (40 mg/mL) or SPM (50 
mM) was transparent, however, a turbid white solution of PIC was generated when an 
equivalent volume of CS and SPM solution were fully mixed with one another. 
Furthermore, after approximately 20 min of settling, the turbid white solution 
separated into two layers. The upper layer was the aqueous phase, while the lower 
layer was the PIC phase. But after being thoroughly mixed again using a vortex mixer, 
the deposited PIC solution could be restored back to a uniform solution. 
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I II III IV
 
Fig. 1-6 Photographs of (I) 40 mg/mL of CS, (II) 50 mM of SPM, (III) PIC, (IV) 
PIC that separated into two layers after standing for about 20 min. 
 
 
Morphological characterization of the PIC showed that it was of spherical shape 
and in a micrometer size range, correlating closely with the particle size (3.41 ± 0.64 
μm) measured by dynamic light scattering (Fig. 1-7 and Table 1-1). However, it was 
observed that adjacent PIC particles quite tended to merge with one another, forming 
larger particles. Therefore, even though the PIC solution was well mixed, PIC 
particles with heterogeneously spherical shapes could still be observed under the 
microscope. 
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CS-A/SPM
 
Fig. 1-7 Microscopic image of PIC generated from 15 kDa of CS and SPM. 
The scale-bar indicates 20.0 μm. 
 
 
PIC formation
40 mg/mL of 15 kDa CS + 50 mM of SPM 3.41 ± 0.64 -0.80 ± 0.25
20 mg/mL of 8 kDa CS + 50 mM of SPM 2.95 ± 2.52 -9.94 ± 0.52
20 mg/mL of 5 kDa CS + 20 mM of SPM 1.64 ± 1.61 -1.96 ± 1.35
80 mg/mL of 46 kDa CS + 100 mM of SPM 4.17 ± 2.92 -11.82 ± 0.86
40 mg/mL of 15 kDa CS + 20 mM of Cdp 1.65 ± 0.53 -25.19 ± 1.03
80 mg/mL of 15 kDa CS + 20 mM of Cdh 2.00 ± 1.26 -32.93 ± 0.47
40 mg/mL of 15 kDa CS + 20 mM of Taa 0.42 ± 0.16 -34.67 ± 1.15
Mean ± SD, n  = 3.
ζ (mV) MV (μm)
Table 1-1 The sizes and ζ-potentials of PIC particles generated under the optimal mixing ratio
conditions between CS and polyamines.
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Fig. 1-8 shows the generation scheme of PIC by mixing CS and SPM. We 
considered that SPM and CS combined with each other by the electrostatic interaction 
between amino groups in SPM and sulfo groups and carboxyl groups in CS. 
 
 
 
Fig. 1-8 The generation scheme of poly-ion complex (PIC) by SPM and CS. 
 
 
1.3.2. Effect of Mixing Concentration Ratio Between CS and SPM on 
PIC Formation Efficiency 
    To understand the properties of PIC, the PIC formation efficiency was firstly 
investigated under different mixing ratios of CS and SPM concentrations. We 
evaluated the PIC formation efficiency by turbidimetric measurement at 600 nm, 
namely to determine the % transmittance (T) using spectrophotometer. The PIC 
formation efficiency was separated into 5 grades and representative examples for each 
evaluation level were presented in Fig. 1-9-1: -, PIC formation could not be observed 
(≧90%T); +, PIC formation was poor (30~89%T); ++, PIC formation was good 
(10~29%T); +++, PIC formation was very good (1~9%T) and after 24 h still exhibited 
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strongly turbid white solution; ++++, PIC formation was the best of all conditions 
(<1%T) but PIC precipitated very quickly (within several seconds). The 
transmittances for the representative examples were 99.2%T (-), 30.6%T (+), 11.8%T 
(++), 3.2%T (+++) and 0.6%T (++++), respectively. 
 
 
++- + +++++++
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Fig. 1-9-1 Representative instances for each evaluation level of PIC 
formation efficiency. 
 
 
15 kDa of CS and SPM were separately dissolved in double-distilled water at 
different concentrations, and then same volumes of CS solution and SPM solution 
were well mixed with one another to generate PIC. As the result shown in Fig. 1-9-2, 
the PIC generated from 40 mg/mL of 15 kDa CS and 50 mM of SPM possessed the 
optimal formation efficiency. PIC formed by higher or lower concentration of CS 
didn’t have so good formation efficiency as this mixing condition. Similarly, SPM at 
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higher or lower concentration also did not avail the PIC formation. Therefore, it was 
demonstrated that the mixing ratio of CS and SPM was one important factor that 
affected the PIC formation efficiency. And this optimized PIC condition was used for 
the next experiment. 
 
 
10 mM 20 mM 50 mM 100 mM
10 mg/mL
20 mg/mL
40 mg/mL
80 mg/mL
200 mg/mL
SPM·4HCl
CS
(bovine tracheal
cartilage)
Mw. 15 kDa
 
Fig. 1-9-2 PIC formation efficiencies under different conditions of mixing 
concentration ratio between 15 kDa CS and SPM. 
 
 
1.3.3. Effect of pH Value on PIC Formation Efficiency 
    Next, the effect of pH value on the optimized PIC sample was examined under 
various pH conditions. Based on our previous results, the PIC formation could not be 
observed under strongly basic conditions (pH > 11) (data not shown). Therefore, the 
purified PIC particles that were generated under diverse pH conditions were 
dissociated by the addition of sodium hydroxide, and then SPM was separated from 
CS using 10 K cut-off spin columns. The resulting free CS and SPM were 
quantitatively determined by HPLC for calculating the ratio of their contents that were 
combined in PIC under different pH conditions (Fig. 1-10). The experiments were 
repeated twice with reproducible results. Consequently, it was observed that the PIC 
formation efficiency was the highest at pH 6.0. Supposing the molecular weight of CS 
is uniform, we are able to calculate that approximately 10 molecules of SPM 
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(correspond to 40 positive charges) bound to one molecule of 15 kDa (dp30) of CS 
(correspond to 60 negative charges). The observation that weakly acidic conditions 
are most suitable for the PIC formation can be explained by the combination ratio 
between 40 positive charges from amino groups of SPM (4 amino groups /SPM × 10 
mol) , and 60 negative charges from sulfo and carboxyl groups of CS (2 negative 
charges /disaccharide unit × dp30). Moreover, this was also consistent with the 
analysis for the characteristic properties of PIC that the ζ-potential was -0.80 ± 0.25 
mV (Table 1-1). 
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Fig. 1-10 The contents of SPM and 15 kDa of CS in PIC at diverse pH values. 
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1.3.4. Effect of the Molecular Size of CS on PIC Formation Efficiency 
LMWCS with molecular weight of 8 kDa and 5 kDa were gained at the reaction 
time of about 7 and 15.5 h, respectively (Fig. 1-11-1). The chemical structure of 
LMWCS was confirmed by the 
1
H-NMR spectra (Fig. 1-11-2). It was revealed that 
the characteristic proton NMR signals observed from 15 kDa CS were also confirmed 
from LMWCS spectrum. Therefore, it was declared that the sugar chain structure of 
CS was still retained after the photodegradation reaction. Moreover, the relative peak 
intensity at 4.9 ppm (GalNAc(4S) H-4) and 4.4 ppm (GalNAc(6S) H-6) almost kept 
unvaried, which demonstrated that the photodegradation method utilizing titanium 
dioxide to produce LMWCS scarcely caused desulfurization. 
 
 
 
Fig. 1-11-1 Molecular weight of LMWCS at different light exposure time. 
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Fig. 1-11-2 One-dimensional 
1
H-NMR spectra (400 MHz) of CS-A and LMWCS. 
 
 
The effect of molecular weight of CS on PIC formation was investigated using 
46 kDa, 8 kDa and 5 kDa CS. These CS samples were similarly dissolved in water 
and the conditions to generate a maximum PIC with SPM were explored. As a result, 
the optimal conditions for PIC formation were different among the various chain 
lengths of CSs (Fig. 1-12). Moreover, efficiency of PIC formation behaved in a CS 
molecular weight-dependent manner. CS with lower molecular size almost did not 
form PIC, while CS with higher molecular weight was more effective for the PIC 
generation. Similarly to PIC formed by 15 kDa CS, the spherical PIC particles 
generated from LMWCS were also observed when PIC solutions were adequately 
mixed. The size and shape of PIC could not be maintained for long time because 
adjacent PIC particles were extremely prone to merging with one another (data not 
shown). Especially, we noticed that 46 kDa of CS generated considerable PICs, 
however these PIC particles precipitated very quickly within several seconds. 
 26 
Interestingly, the surface charges of PIC coming from 8 kDa or 46 kDa of CS were 
significantly different from those of PIC generated by 15 kDa or 5 kDa of CS despite 
an almost identical particle size of PIC (Table 1-1). In contrast with the ζ-potentials of 
the PICs, coming from 15 kDa and 5 kDa of CS, being near 0 mV, the PICs formed 
using 8 kDa and 46 kDa of CS showed ζ-potentials around -10 mV. 
 
 
10 mM 20 mM 50 mM 100 mM
10 mg/mL
20 mg/mL
40 mg/mL
80 mg/mL
200 mg/mL
Low Molecular
Weight CS
Mw. 5 kDa
SPM·4HCl
10 mM 20 mM 50 mM 100 mM
10 mg/mL
20 mg/mL
40 mg/mL
80 mg/mL
200 mg/mL
Low Molecular
Weight CS
Mw. 8 kDa
SPM·4HCl
10 mM 20 mM 50 mM 100 mM
10 mg/mL
20 mg/mL
40 mg/mL
80 mg/mL
200 mg/mL
SPM·4HCl
CS
(shark cartilage)
Mw. 46 kDa
 
Fig. 1-12 Effect of the molecular weight of CS on the PIC formation efficiency. 
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1.3.5. Effect of Unusual Polyamines on PIC Formation Efficiency 
It has been known that thermophilic bacteria and archaea are a rich source of a 
wide variety of unusual polyamines. In particular, an extreme thermophile 
(eubacterium), Thermus thermophilus, produces various kinds of unusual polyamines 
such as caldopentamine (Cdp), caldohexamine (Cdh), tris (3-aminopropyl) amine 
(Mitsubishine) and tetrakis (3-aminopropyl) ammonium (Taa) (Fig. 1-5).
28)
 Since 
unusual polyamines, especially Taa, stabilize ssDNA and tRNA more effectively than 
SPM, the effect of the unusual polyamines on PIC formation with 15 kDa of CS was 
examined under lower concentration conditions. As displayed in Fig. 1-13-1, the 
optimal conditions of PIC formations were various among the unusual polyamines. 
Particularly, Mitsubishine was unable to form PIC with 15 kDa of CS, in contrast to 
the strong PIC formation observed for well mixed by the equivalent volumes of 40 
mg/mL of 15 kDa CS and 20 mM Taa. Although amount of the resulting PIC particles 
coming from Taa was almost equal to that from SPM after the PIC solutions separated 
into layers, the configuration and the color of the PIC generated by Taa was obviously 
different (Fig. 1-13-2). Furthermore, it was observed that PIC coming from Taa 
maintained its particle size for a relatively longer time (more than 1 h) and the 
particles did not quickly merge into one another (Fig. 1-13-3). The particle size of the 
PIC formed by Taa was the smallest (0.42 ± 0.16 μm) among all the PICs examined, 
however, Taa afforded the lowest ζ-potential value (-34.67 ± 1.15 mV) (Table 1-1). 
The reason for this may be because Taa can bind to CS more effectively than any of 
the other polyamines.
28)
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1 mM 2 mM 5 mM 10 mM 20 mM
20 mg/mL
40 mg/mL
80 mg/mL
1 mM 2 mM 5 mM 10 mM 20 mM
20 mg/mL
40 mg/mL
80 mg/mL
1 mM 2 mM 5 mM 10 mM 20 mM
20 mg/mL
40 mg/mL
80 mg/mL
1 mM 2 mM 5 mM 10 mM 20 mM
20 mg/mL
40 mg/mL
80 mg/mL
CS (bovine
tracheal cartilage)
Mw. 15 kDa
Caldopentamine·5HCl (Cdp·5HCl)
Caldohexamine·6HCl (Cdh·6HCl)
CS (bovine
tracheal cartilage)
Mw. 15 kDa
Tetrakis(3-aminopropyl)ammonium·5HCl (Taa·5HCl)
CS (bovine
tracheal cartilage)
Mw. 15 kDa
Tris(3-aminopropyl)amine·4HCl (Mitsubishine·4HCl)
CS (bovine
tracheal cartilage)
Mw. 15 kDa
 
Fig. 1-13-1 Effect of unusual polyamines on the PIC formation efficiency. 
 
 
CS-A / SPM CS-A / Taa CS-A / SPM CS-A / Taa
after 
20 min
 
Fig. 1-13-2 Photographs of the PIC (15 kDa CS-A+SPM) and PIC (15 kDa CS-A+Taa). 
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CS-A/Taa
 
Fig. 1-13-3 Microscope image of PIC generated from 15 kDa of CS and Taa.  
The scale-bar indicates 20.0 μm. 
 
 
It is thought that the maintenance of PIC particle size is an important factor to 
improve the absorption efficiency of the PIC in gastrointestinal tract. In general, CS 
chains may exist as a linear form in neutral pH and the electrostatic repulsion of each 
sulfonate/carboxyl group of CS chain must affect their coagulation. However, once 
some parts of negatively charged acidic groups of CS were electronically neutralized 
by amines, it might be allowed to change their forms in solution as a complex. As 
mentioned above, PIC formations by the combination of CS (5 kDa, 8 kDa, 15 kDa 
and 46 kDa) and linear polyamines such as SPM, Cdp and Cdh were successfully 
conducted. However, their particles were extremely prone to merging with one 
another. It is conceivable that PIC particles obtained by the electrical attachment of 
linear polyamines to linear CS in the parallel positions are unable to keep their size.  
In the case of branched polyamines, Taa and Mitsubishine showed different PIC 
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formation with linear CS. Especially, Taa exhibited the generation of different type of 
PIC compared with any of the other polyamines, suggesting that Taa but not 
Mitsubishine maybe caused the structural changes of CS (or bridge connection 
between CSs) and consequently maintained the PIC particle size. In the light of these 
observations, we speculate that maintenance of the size of PIC generated by CS and 
polyamines requires structural changes of CS based on the binding with branched 
polyamines possessing numerous positively charged amino groups. Experiments are 
in progress to develop the more stable PIC generation using branched polyamines. 
 
1.3.6. Effect of PIC Formation on the Oral Intake of CS in Animal 
Models 
There have been several experiments evaluating the nanoparticles that have 
permeating activity into the epithelial cell layer.
49-52)
 However, there are two issues for 
evaluation of PIC generated in this study. One is the toxicity of extracellular SPM 
because amine oxidase in fetal calf serum produces aminodialdehyde-generating 
acrolein.
53)
 The other is the stability of PIC particles formed in this study, because 
adjacent PIC particles quite tended to come together and make one larger particle, 
which might influence the oral intake efficiency of PIC. For this reason, the effect of 
PIC formation on the oral intake of CS was directly evaluated in vivo. 
    Under our experimental conditions, orally absorbed CS was observed in the 
plasma of only one mouse in the total 7 mice (14.3% of mice) without any injury 
caused by scratching in the 15 kDa CS (500 mg CS/kg body weight) dosed group (Fig. 
1-14a). In the case of colitis model mouse, induced by dextran sulfate,
54)
 a significant 
level of 15 kDa of CS was absorbed by the inflamed colon (data not shown), while we 
did not find any inflammation in intestine or colon of mice in this study by surgical 
operation after the experiments. Subsequently, PIC was orally administered to mice at 
a single dose of 500 mg CS/kg body weight and the plasma concentration—time 
profiles of CS were plotted (Fig. 1-14b). CS concentration in plasma increased in 4 
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mice in the total 9 mice (44.4% of mice) when PICs, generated from 15 kDa of CS 
and SPM, were treated to mice. Generally, a lower molecular weight CS is regarded as 
better absorbed than a greater CS, however, the PICs generated from 8 kDa and 5 kDa 
CS almost did not help increase the CS oral absorption efficiency (Figs. 1-14c and d). 
Moreover, the effective absorption of PIC formed by 46 kDa CS and SPM or PIC 
generated by 15 kDa CS and Taa was hardly observed (Figs. 1-14e and f).  
 
Fig. 1-14 Effect of PIC formation on the oral intake of CS in mice. 
CS contents in the plasma of mice orally administrated with CS alone or PIC were determined 
following the “Experimental”. Each profile represents one mouse.  
 32 
 
To better understand the absorption of PIC, the ζ-potentials of various kinds of 
PIC particles were subsequently determined under their corresponding mixing ratio 
conditions for the best PIC formation efficiency. As a result, the PIC generated by 15 
kDa of CS and SPM possessed nearly electrically neutral particle surface charges, 
while other PIC particles (except for the mixing ratio condition of 5 kDa CS and 
SPM) were negatively surface charged (Table 1-1 and Fig. 1-15). 
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Fig. 1-15 The determination of PIC particle size and surface charge. 
 
 
If PIC having neutral surface charge is critical for the absorption in 
gastrointestinal tract, it is important to better understand the condition of PIC derived 
from various length of CS. In the case of 15 kDa CS (dp30), we determined that 
approximately 10 molecules of SPM (correspond to 40 positive charges) bound to one 
molecule of 15 kDa CS (correspond to 60 negative charges) when CS (40 mg/mL) 
and SPM (50 mM) were mixed (Fig. 1-10). If the mixing ratio between the number of 
anionic groups in CS (5 kDa, 8 kDa or 46 kDa) and that of cationic groups in SPM 
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also obeyed this ratio between 15 kDa CS (40 mg/mL) and SPM (50 mM), similar 
PICs having nearly neutral surface charges were obtained (Table 1-2). The ζ-potentials 
of PIC particles generated by 40 mg/mL of various lengths of CSs and 50 mM SPM 
were -3.12 ± 8.96 mV (5 kDa CS), -2.96 ± 2.35 mV (8 kDa CS) and -3.62 ± 0.54 mV 
(46 kDa CS), respectively. However, it should be noted that PIC amounts obtained 
under these conditions were less, compared with the optimal mixing ratio conditions 
(Fig. 1-12). In the case of 5 kDa CS, the mixing condition of 20 mg/mL of 5 kDa CS 
+ 20 mM SPM also afforded the PIC having nearly neutral surface charge (Table 1-1), 
however, substantial absorption was not observed (Fig. 1-14d), which was probably 
due to the lower PIC formation efficiency. These results indicate that the high 
formation efficiency and electrically neutral surface charge of PIC particles are both 
important factors for their effect on oral CS bioavailability. 
 
 
PIC formation
40 mg/mL of 5 kDa CS + 50 mM of SPM
40 mg/mL of 8 kDa CS + 50 mM of SPM
40 mg/mL of 46 kDa CS + 50 mM of SPM
Mean ± SD, n  = 3.
Table 1-2. The ζ-potential of PIC particles generated under the mixing ratio
condition of negative charges in CS : positive charges in poliamines = 60 : 40.
-3.62  ±  0.54
-2.96  ±  2.35
-3.12  ±  8.96
ζ (mV) 
 
 
 
Unfortunately, it was yet unclear why the detected amounts of CS, which was 
absorbed in the oral PIC form, were so uneven in plasma samples of individual mice 
(Fig. 1-14b). We assume that under the physiological conditions in the intestine (pH 7 
~ 8), the PIC particles probably will be dissociated according to the results from Fig. 
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1-10, which may be one reason that inhibits the PIC oral absorption. Furthermore, the 
PIC particles formed by CS and SPM are unstable and easily merge with one another, 
possibly also influencing the oral intake efficiency of PIC.  
In light of these observations, the more stable PIC particles simultaneously 
possessing high formation efficiency and neutral surface charges might represent a 
promising core structure for further development of oral CS delivery system. 
 
 
 
 
1.4. Summary 
The formation of PIC was found through the electrostatic interaction between CS 
and polyamines in water solutions. Thus, the physicochemical properties of PICs were 
investigated in the aqueous phase. It was demonstrated that the efficiency of PIC 
formation was influenced by various factors including the mixing concentration ratio 
of CS and polyamines, the molecular weight of CS, the nature of polyamines and pH 
value. The optimal PIC sample generated from 15 kDa of CS and SPM was the most 
stable at pH 6.0 and combining molar ratio of CS∶SPM was 1∶10. This PIC 
formation afforded a particle size of 3.41 ± 0.64 μm and a ζ-potential of -0.80 ± 0.25 
mV. Furthermore, based on the in vivo experiments, the PIC generated from SPM and 
15 kDa of CS had the best absorption by oral administration when compared to CS 
alone or other PICs. PICs generated by 15 kDa of CS and Taa were the most stable 
PICs with particle size of 0.42 ± 0.16 μm, despite their undesirable negative 
ζ-potential. In conclusion, PIC utilizing polyamines appears to be a promising core 
structure for the development of CS delivery system. The high formation efficiency 
and electrically neutral surface charge of PIC particles are both important factors for 
their effect on oral CS bioavailability. 
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Chapter 2 
The formation and characterization of poly-ion complex generated 
through the interaction between heparin and polyamines 
 
2.1. Introduction 
Heparin (HP), another member of the GAG family, consists of a (α 1→4) linked 
repeating disaccharide unit that is composed of glucuronic acid or iduronic acid along 
with glucosamine. Unfractionated heparin is a heterogeneous polydispersed mixture 
of sulfated polysaccharides substituted with O-sulfo groups or N-sulfo groups at 
different positions. The molecular weight of heparin ranges from 3 kDa to 30 kDa 
with an average molecular mass of 15 kDa.
15-17)
 Heparin is widely used as 
an anticoagulant in the clinical researches and can bind to the serine protease inhibitor 
antithrombin (AT), causing it to undergo a conformational change resulting in AT 
inhibition of thrombin (Factor IIa) and Factor Xa. AT binds to the specific 
pentasaccharide sequence [GlcNAc6S (1→4) GlcA (1→4) GlcNS3S6S (1→4) 
IdoA2S (1→4) GlcNS6S)] in heparin (Fig. 2-1).46,55) However, similarly to CS, the 
oral bioavailability of heparin is pretty low because of its high molecular weight 
(3~30 kDa) and the highest negative charge density of any known biological molecule. 
Accordingly, heparin is only used as intravenous or subcutaneous injection but not 
preparation for oral use, which severely limits its application.  
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O
O
O
O
O
O
O
O
O
O
OH
NHCOCH3 OH NHSO3
- OSO3
- NHSO3
-
OH
COOH
OSO3
-
OSO3
-OSO3
-OSO3
-
OH
COOH
OH
 
Fig. 2-1 The pentasaccharide sequence in heparin that binds to antithrombin. 
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There have been several reports demonstrating that the conjugation of 
hydrophobic bile acids with low molecular weight heparin (LMWHP) allowed 
effective absorption in the intestine through binding with bile acid transporter found 
on the apical epithelial cell membrane.
49-52)
 In the clinical researches, unfractionated 
heparin exhibits some undesirable side effects. Thus, low molecular weight heparin, 
with sustained antithrombotic activity, more predictable pharmacological action, and 
better bioavailability,
18,56-58)
 has been introduced as heparin substitute for reduced side 
effects. The most common commercially available LMWHP includes Enoxaparin, 
Dalteparin and so on. 
Under the inspiration of poly-ion complex (PIC), in this study we attempted to 
mix heparin and natural polyamines in aqueous solutions. Similarly to CS, the 
formation of turbid white PIC was also found through the electrostatic interaction 
between heparin and polyamines in water solutions and we also investigated whether 
the generated PIC effected on heparin oral absorption or not. 
 
 
 
 
2.2. Experimental 
2.2.1. Chemicals and Materials 
Heparin (average molecular weight: 20 kDa, extracted from porcine intestine) 
was purchased from New Zealand Pharmaceutical Co., Ltd. Putrescine 
dihydrochloride (PUT·2HCl), Spermidine trihydrochloride (SPD·3HCl) and Spermine 
tetrahydrochloride (SPM·4HCl) were obtained from Nacalai Tesque Inc. (Kyoto, 
Japan). The heparin assay kit containing Factor Xa, Normal human plasma, 
Antithrombin III and the coloring synthetic substrate S-2222 was purchased from Test 
Team Heparin S
®
, Sekisui Medical Co., Ltd (Tokyo, Japan). Water used in studies was 
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purified using Q-GARD
®
 1, Millipore. All other chemicals were of analytical reagent 
grade and used without further purification. 
 
2.2.2. PIC Formation 
Similarly to case of CS, heparin and polyamines were separately dissolved in 
double-distilled water, with a doubled concentration of the target PIC, and then 
equivalent volumes of heparin solution and polyamine solution were fully mixed with 
each other to generate PIC. PIC formation efficiency was evaluated by turbidimetric 
measurement at 600 nm, namely the determination of % transmittance (T), using 
thermo scientific SPECTONIC 20D+ digital spectrophotometer, and was expressed as 
-, +, ++ and so on same as Chapter 1. 
 
2.2.3. Effect of Mixing Concentration Ratio Between Heparin and 
Polyamines on PIC Formation Efficiency  
To understand the effect of mixing ratio between heparin and polyamines on PIC 
generation, the PIC formation efficiencies were evaluated under different mixing 
concentration ratio conditions between 20 kDa of heparin extracted from porcine 
intestine and SPM/SPD/PUT.  
 
2.2.4. The ζ-Potential Determination 
Similarly to the case of CS, the ζ-potential determination was performed for the 
PIC sample generated from heparin and polyamines on the ELS-Z1 (Otsuka 
Electronics Co., Ltd, Osaka, Japan) at the 60 V of voltage. Double-distilled water was 
used as the dispersant and the measurements were carried out at 25°C. The average of 
three measurements was taken as the final characteristic parameter. 
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2.2.5. Effect of PIC Formation on the Oral Intake of Heparin in 
Mouse Models 
    All animal experiments were approved by the Institutional Animal Care and Use 
Committee of Chiba University and carried out according to the guidelines for Animal 
Research of Chiba University. The ddY mice (female, weighing 28 - 30 g, Japan SLC, 
Inc, Shizuoka, Japan) were housed at 25°C and 55% RH. A 12 h dark/light cycle was 
maintained throughout. Mice had free access to standard pellet diet (MF, Oriental 
Yeast Co., Ltd, Tokyo, Japan) and tap water, and were fasted overnight before the 
experiment, because it was considered that the diet might contain heparin and 
influence the experiment results. The solution containing fully mixed PIC or heparin 
alone was orally administered to each group (comprising 6 mice) at a single dose of 
500 mg HP/kg body weight (ca. 15 mg HP/each animal). Blood samples were 
collected from the tail vein at time intervals of 0, 0.5, 1, 2, 3, 4, 6 h after oral 
administration and were anticoagulated with 3.2% trisodium citrate solution at the 
ratio of blood : 3.2% trisodium citrate = 9 : 1. Each collected sample was immediately 
centrifuged at 800 g for 15 min to obtain the plasma, which was transferred to a new 
Eppendorf tube and stored in a deep freezer until used. The schedule of oral 
administration of PIC in animal models was similar to Fig. 1-3 described previously 
with minor modifications. 
 
2.2.6. Determination of Heparin Contents in Mouse Plasma 
    The contents of heparin that were absorbed into the mouse plasma via oral route 
were determined by the Anti-Factor Xa Activity Assay using heparin assay kits. 
 
Preparation of Standard Solutions 
    Clexane kit for subcutaneous injection (2000 IU/0.2 mL) was utilized as the 
standard sample. The standard sample was firstly diluted to 10 IU/mL with 0.9% NaCl 
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solutions and then further diluted to 0.2 IU/mL with Tris buffer (pH 8.4). 
0/20/40/60/80 µL of the diluted standard samples were dissolved with 
160/140/120/100/80 µL of Tris buffer (pH 8.4), respectively, and then 20 µL of 1 
U/mL ATIII and 20µL of normal human plasma were serially added to each sample. 
Thus, 0/0.2/0.4/0.6/0.8 IU/mL plasma of standard solutions was acquired for plotting 
the calibration curve. 
 
Preparation of Specimen Solutions 
    5 µL of each collected mouse plasma sample was diluted with 15 µL of the 
normal human plasma and then dissolved with 160 µL of Tris buffer (pH 8.4), 
followed by the addition of 20 µL of 1 U/mL ATIII. The final 200 µL of specimen 
solution was obtained for determination (Fig. 2-2). 
 
Determination 
    As shown in Fig.2-2, 200 µL of the standard solutions or specimen solutions 
were incubated at 37°C for 5 min and then added with 100 µL of 7.1 nkat/mL factor 
Xa solution that was excessive for the reaction. After incubation at 37°C for exact 30 
seconds, 200 µL of 0.75 mg/mL S-2222 solution was added as the substrate to react 
with the excessive factor Xa at 37°C for 3 min. Subsequently, 300 µL of 50% acetic 
acid was added to stop the reaction and the production of free p-nitroaniline was 
detected for the absorbance at 405 nm using TECAN Austria GmbH Sunrise Thermo 
(made in Austria). The calibration curve was constructed using the anti-factor Xa 
activity of standard solutions (IU/mL plasma) plotted against absorbance and the 
anti-factor Xa activity of each specimen was calculated from this calibration curve. 
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Plasma 5 µL
add  normal human plasma 15 µL
add  Tris buffer (pH 8.4)                  160 µL
add  anti-thrombin III           20 µL
Specimen                                                    200 µL
Specimen or Standard                             200 µL
Incubation at 37℃ for 5 min
add factor Xa 100 µL
Incubation at 37℃ for 30 s
add substrate (S-2222)                      200 µL
Incubation at 37℃ for 3 min
add 50% acetic acid                          300 µL
Determine the absorbance at 405 nm 
 
Fig. 2-2 Procedures for determination of anti-factor Xa activity. 
 
 
 
 
2.3. Results and Discussion 
2.3.1. Preparation of Poly-ion Complex 
    Similarly to the case of CS, in this study we also firstly examined whether 
polyamine SPM could aggregate with the glycosaminoglycan heparin obtained from 
porcine intestine with an average molecular weight of 20 kDa. As the result shown in 
 41 
Fig.2-3, the aqueous solution containing heparin (20 mg/mL) or SPM (20 mM) was 
clear and transparent, however, the turbid white PIC solution was generated when the 
equivalent volume of heparin and SPM solution were adequately mixed with one 
another. And after being settled for about 20 min, the turbid white solution separated 
into two layers. The upper layer was the water phase, and the lower layer was the PIC 
phase. Furthermore, the deposited PIC solution was restored back to a uniform 
solution after being thoroughly mixed again using vortex mixer. Similarly, we 
considered that PIC was generated through the electrostatic interaction between 
cationic groups in polyamines and anionic groups in heparin. 
 
 
20min
PIC
I II III IV
 
Fig. 2-3 Photographs of (I) 20 mg/mL of Heparin, (II) 20 mM of SPM, (III) PIC, 
(IV) PIC that separated into two layers after standing for about 20 min. 
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2.3.2. Effect of Mixing Concentration Ratio Between Heparin and 
Polyamines on PIC Formation Efficiency  
    20 kDa of heparin and SPM/SPD/PUT were separately dissolved in 
double-distilled water at different concentrations, and then same volumes of heparin 
solution and polyamine solution were well mixed with each other by different mixing 
concentration ratios to generate PIC. The PIC formation efficiency was evaluated as 
Fig. 1-9-1. Consequently, it was found that the PIC generated from 20 mg/mL of 
heparin and 20 mM of SPM afforded the best formation efficiency among various 
cases (Fig. 2-4). Heparin with too low concentration was not able to form PIC and the 
polyamines possessing more positive charges could facilitate the PIC formation. This 
indicated that mixing concentration ratio between heparin and polyamines, as a matter 
of fact, the mixing ratio between the number of anionic groups in heparin and that of 
cationic groups in polyamines, significantly affected the PIC formation efficiency. 
 
 
 
20 mM 100 mM 200 mM 20 mM 100 mM 200 mM 20 mM 100 mM 200 mM
0.02 mg/mL
0.2 mg/mL
1 mg/mL
2 mg/mL
10 mg/mL
20 mg/mL
PUT·2HCl
HP
 SPM·4HCl SPD·3HCl
 
 
Fig. 2-4 PIC formation efficiencies under different conditions of mixing 
concentration ratio between 20 kDa heparin and polyamines. 
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2.3.3. Effect of PIC Formation on the Oral Absorption of Heparin in 
Animal Models 
The effect of PIC on the oral intake of heparin was examined in mouse models. 
Similarly to CS, the solution containing PIC or heparin alone was orally administered 
to mice and then the time course profiles were plotted for the heparin contents in mice 
blood plasma. However, it was regrettable that no mouse showed obvious heparin oral 
absorption in either the control group or the PIC dosed group (Fig. 2-5). In the clinical 
researches, the therapeutic range for heparin was considered to be around 0.5 IU/mL 
plasma anti-FXa activity (expressed as the red dotted line in Fig. 2-5). Thus, in this 
study the PIC formation did not assist to increase the oral heparin absorption at all.  
Subsequently, we investigated the surface charge of the PIC sample and found 
that the ζ-potential was -20.6 ± 0.56 mV. We considered that the extremely negative 
surface charge of the PIC particles could be one important reason that affected the 
heparin oral absorption. 
It has been reported that the N-trimethyl chitosan coated polylactide-co-glycoside 
(ζ-potential: around -10 mV) afforded the positive surface charges on the resulting 
nanoparticles and facilitated the oral absorption.
59)
 Jain et al. also reported the 
preparation of cationic-coated liposome using polyallyl amine hydrochloride.
60) 
These 
reports provide us with a promising approach for developing a cationic coating 
reagent for PIC generated from heparin and polyamines to ultimately improve the 
heparin bioavailability in the future study. 
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Fig. 2-5 Effect of PIC formation on the oral intake of heparin in mice. 
Heparin contents in the plasma of mice orally administrated with heparin alone or PIC were 
determined following the “Experimental”. Each profile represents one mouse. 
 
 
 
 
2.4. Summary 
    The formation of PIC was found by mixing heparin and polyamines in aqueous 
solutions. The PIC was considered to be generated through the electrostatic 
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interaction between cationic groups in polyamines and anionic groups in heparin. The 
PIC formation efficiency was significantly affected by the mixing concentration ratio 
between heparin and polyamines and 20 mg/mL heparin + 20 mM SPM afforded the 
optimal PIC formation among the three kinds of standard polyamines SPM/SPD/PUT. 
However, the in vivo experiments demonstrated that the PIC sample failed to increase 
the oral heparin absorption, probably because of the extremely negative surface 
charge of the PIC particles. Further researches are underway to develop the 
cationic-coated PIC for improving the heparin bioavailability through the 
gastrointestinal tract. 
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Conclusion 
 
    In this study, we focused on the low oral bioavailability of glycosaminoglycans 
and therefore prepared poly-ion complex by mixing glycosaminoglycans and natural 
polyamines in aqueous solutions and investigated their effects on GAG absorption via 
the oral route. Chapter 1 and Chapter 2 aimed at the members of GAG family, 
chondroitin sulfate and heparin, respectively, and experiments were carried out for 
exploring the physicochemical properties and in vivo dynamic process of PICs 
generated from them. 
 
Chapter 1 The formation and characterization of poly-ion complex generated 
through the interaction between chondroitin sulfate and polyamines 
Preparation of poly-ion complex 
    We observed that when the equivalent volume of transparent aqueous solutions 
containing CS and polyamines were fully mixed with one another, a turbid white 
solution of PIC was generated. We considered that polyamines and CS combined with 
each other by the electrostatic interaction between amino groups in polyamines and 
sulfo groups and carboxyl groups in CS. 
  
Physicochemical properties of PIC 
    The physicochemical properties of PIC generated from CS and polyamines were 
investigated in the aqueous phase. It was demonstrated that the efficiency of PIC 
formation was influenced by various factors including the mixing concentration ratio 
of CS and polyamines, the molecular weight of CS, the nature of polyamines and pH 
value. The optimized PIC generated from 40 mg/mL of 15 kDa CS and 50 mM of 
SPM was the most stable at pH 6.0 and the combining molar ratio of CS∶SPM was 
1∶10. This PIC formation afforded a particle size of 3.41 ± 0.64 μm and a ζ-potential 
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of -0.80 ± 0.25 mV.  
 
Effect of PIC formation on the CS oral intake in animal models 
Based on the in vivo experiments, the PICs generated from SPM and 15 kDa of 
CS got the best absorption by oral administration when compared to CS alone or other 
PICs. PICs generated by 15 kDa of CS and Taa were the most stable PICs with the 
smallest particle size, although the substantial absorption was not observed. 
According to the determination of ζ-potential, we consider that the stable PIC 
particles simultaneously possessing high formation efficiency and electrically neutral 
surface charges might represent a promising core structure for further improvement of 
CS bioavailability in the digestive system. 
 
Chapter 2 The formation and characterization of poly-ion complex generated 
through the interaction between heparin and polyamines  
Preparation of PIC 
    Similarly to CS, the formation of turbid white PIC solution was observed after 
equivalent volumes of clear transparent heparin water solution and natural polyamines 
water solution were fully mixed with one another. We considered that PIC was 
generated through the electrostatic interaction between cationic groups in polyamines 
and anionic groups in heparin. 
 
Effect of PIC formation on the heparin oral intake in animal models 
    Similarly to CS, the solution containing PIC or heparin alone was orally 
administered to mice and then the time course profiles were plotted for the heparin 
contents in mice blood plasma. However, it was regrettable that the PIC formation did 
not help increase the oral heparin absorption, maybe because of the strongly negative 
surface charge of the PIC particles. Deeper studies are in progress to further improve 
the oral heparin bioavailability by developing the cationic-coated PIC. 
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